Syra Health Corp. (SYRA)
OTCMKTS · Delayed Price · Currency is USD
0.0691
+0.0016 (2.32%)
At close: Dec 5, 2025

Syra Health Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
1714---
Market Cap Growth
-82.61%-49.59%----
Enterprise Value
-1517---
Last Close Price
0.070.411.02---
PS Ratio
0.160.892.56---
PB Ratio
0.542.483.52---
P/TBV Ratio
0.542.483.52---
EV/Sales Ratio
-0.633.01---
Debt / Equity Ratio
0.110.160.061.32-47.97-0.72
Debt / EBITDA Ratio
----11.86-
Asset Turnover
1.951.861.523.935.22-
Quick Ratio
2.765.014.850.870.850.42
Current Ratio
3.055.475.250.920.850.42
Return on Equity (ROE)
-45.71%-109.09%-124.42%-602.65%--
Return on Assets (ROA)
-20.65%-54.71%-49.84%-91.44%-0.76%-
Return on Capital (ROIC)
-25.05%-61.99%-61.11%-131.88%-1.23%-
Return on Capital Employed (ROCE)
-57.50%-122.80%-72.00%-270.20%-3.90%1228.80%
Earnings Yield
-105.73%-52.73%-20.78%---
FCF Yield
--41.28%-19.62%---
Buyback Yield / Dilution
-69.45%-54.81%59.02%13.44%--
Source: S&P Capital IQ. Standard template. Financial Sources.